iSOFT Adds New Functionality to UK Laboratory Systems

iSOFT Group LimitediSOFT Group Limited, one of the world's largest healthcare IT companies, will release a series of new functions for its i.Laboratory range of pathology solutions and create a UK-based development team to advance the capability of the laboratory business to meet local needs.

The new modules for i.Laboratory will be available ahead of a major user group forum at the International Convention Centre (ICC) in Birmingham on 10-11 June. As well as a platform for demonstrating the new modules, iSOFT will also provide a forum for customers to inform future developments to realise the benefits of current systems.

To ensure iSOFT's UK customers remain at the forefront of laboratory information system technology (LIS), iSOFT has recently created a local development team in the UK. This will grow rapidly to provide a full laboratory development capacity focused on local requirements.

"These significant developments clearly demonstrate our commitment to LIS customers in the UK and Ireland and to growing our market share," said Adrian Stevens, Managing Director of iSOFT’s UK and Ireland business. "The investment in technology and people is a reflection of the importance of the UK LIS market to iSOFT and we will continue to invest to maintain our leadership position.

"The solutions being developed will provide significant new and updated functionality to meet customer needs and ensure they remain at the forefront of laboratory technology," Stevens said. "Our approach means that users can take immediate advantage of powerful new functionality that will begin their journey on to a technology platform designed for the next phase of the evolution of laboratory services in the UK and globally. This means that even as our customers implement discrete functionality to improve business performance in one area or discipline, they will be building the organisation-wide capability to help deliver a laboratory service of the future. The new offerings will help manage information and reduce the time to turnaround test results and will improve the quality of care and cut costs, which is vital in the current economic climate."

Separately iSOFT has also been awarded a contract by NHS Connecting for Health to develop a solution for GPs and other primary care users to request pathology tests and receive results online. The module will work with all major GP systems and is planned for full release in the second half of 2010.

iSOFT has 150 customers in the NHS and Ireland for its laboratory solutions, giving it a 65% share of the market.

The UK development team will create new functions for all i.Laboratory Apex and i.Laboratory TP users, including:

  • GP Test Results Requesting and Reporting
  • Full word processing and digital dictation for cellular pathology
  • Cancer Histopathology Reporting module
  • Dedicated laboratory interface manager
  • Standardised Business Intelligence
  • Infection control
  • Enhanced disease screening - eGFR, stroke risk calculation and CHD risk calculation
  • Cervical cytology
  • New and improved Graphical User Interface
  • Digital solutions for lab-to-lab interconnectivity
  • Configurable dashboards

"With a large installed base in Europe, iSOFT remains one of the continent's largest providers of laboratory information systems," said Gary Cohen, iSOFT's Executive Chairman and CEO. "These and other developments put us in prime position to capitalise on the growth in this sector and deliver solutions at a local and national level to meet the future needs of public and private laboratory services."

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in about 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...